Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.9%

4 terminated out of 68 trials

Success Rate

90.7%

+4.2% vs benchmark

Late-Stage Pipeline

24%

16 trials in Phase 3/4

Results Transparency

15%

6 of 39 completed with results

Key Signals

6 with results91% success

Data Visualizations

Phase Distribution

45Total
Not Applicable (26)
P 1 (1)
P 2 (2)
P 3 (7)
P 4 (9)

Trial Status

Completed39
Unknown16
Withdrawn6
Terminated4
Recruiting3

Trial Success Rate

90.7%

Benchmark: 86.5%

Based on 39 completed trials

Clinical Trials (68)

Showing 20 of 20 trials
NCT03334006Phase 2RecruitingPrimary

Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis

NCT04604730Not ApplicableRecruitingPrimary

Role of Protective Stoma After Primary Anastomosis for Generalized Peritonitis Due to Perforated Diverticulitis

NCT00692393Not ApplicableCompletedPrimary

Primary vs. Secondary Anastomosis for Hinchey Stage III-IV Diverticulitis a Prospective Randomized Trial

NCT07531576Not ApplicableCompletedPrimary

Outcome of Primary vs Delayed Primary Closure of Laparotomy in Dirty Abdominal Wounds

NCT04577339Completed

The Best Care for Abdominal Emergencies Study

NCT02805049Phase 4Completed

Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study)

NCT05684198Not ApplicableCompletedPrimary

NPWT vs Primary Closure in SSI Prevention for Emergency Laparotomies for Peritonitis

NCT03069131Phase 3Completed

Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites

NCT06296953Not ApplicableCompleted

Safety & Feasibility of PERIsign System in Demonstrating Involuntary Muscle Defense as a Sign of Peritonitis in Subjects With Appendicitis

NCT04624451TerminatedPrimary

Evaluation of Intravenous Dalbavancin for Peritonitis

NCT04070196Not ApplicableCompletedPrimary

Point-of-care Test for Diagnosis of Peritonitis in Peritoneal Dialysis Patients

NCT02755610Not ApplicableUnknown

Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis

NCT01785641Not ApplicableCompletedPrimary

Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD Patients

NCT05050253Not ApplicableUnknownPrimary

Lavage With Super-Oxidized Solution for Secondary Peritonitis

NCT03426943Not ApplicableCompleted

Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris™

NCT05285436Not ApplicableUnknown

A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis

NCT04126577CompletedPrimary

Clinical Relevance of the Reverse Lipopolysaccharide Transport Pathway in Patients With Acute Peritonitis

NCT05893095Completed

Evaluation of Laparoscopic Peritoneal Lavage for Perforated Diverticulitis: A National Registry - Based Study

NCT04033614Not ApplicableRecruiting

Fasciotens to Treat an Open Abdomen - a Prospective Cohort Study

NCT03668197CompletedPrimary

Children Peritonitis Ecology at CHU de Rennes - (IIAPEDIA)

Scroll to load more

Research Network

Activity Timeline